ABSTRACT
INTRODUCTION
The proteinuria and elevated serum creatinine levels that result from glomerular disease are associated with cardiovascular morbidity and renal failure. Glomerular disease continues to be the leading cause of end-stage renal disease (ESRD) and is associated with a high morbidity and mortality, as well as with an increase in the financial costs to the healthcare system (1, 2) worldwide. Primary glomerular diseases (PGD), diagnosed by renal biopsy, have been the predominant form of renal disease reported in many studies from China (3), the Kingdom of Bahrain (4) and Senegal (5) . This might be explained by the low rate of renal biopsy for secondary glomerular disease. Many doctors believe that once a diagnosis of secondary glomerular disease is established as the clinical diagnosis, treatment can be implemented. However, it is well known that a renal biopsy plays a fundamental role not only in establishing an accurate diagnosis but also in deciding the appropriate treatment and prognosis. A number of cases have been diagnosed based only on clinical findings at basic-level hospitals in China; at these institutions, some renal physicians do not perform renal biopsies and some patients might decline such procedures.
The prevalence of biopsy proven glomerulonephritis varies according to race, age, geographic regions, socioeconomic conditions and the indications for a renal biopsy. However, there is no valid data on the epidemiology of glomerulonephritis in Shandong, China, to date. Therefore, in order to determine the relationship between the clinical findings and renal pathology of PGD, we collected renal biopsy data from 22 basic-level hospitals in Shandong, China.
SUBJECTS AND METHODS
Native Chinese patients from 22 basic-level hospitals in Shandong, China, were included in this study from January 2008 to June 2013. The indications for renal biopsy included proteinuria, unexplained microscopic or macroscopic haematuria and systemic disease with evidence of renal involvement, and mild-to-moderate renal impairment. All samples were obtained by percutaneous methods using a Tru-Cut ® biopsy needle under ultrasound guidance. Patients' age and clinical findings were systematically collected at the time of the renal biopsy. Primary glomerular diseases include the following: nephrotic syndrome, nephritic syndrome, asymptomatic urinary abnormalities, acute renal failure and chronic renal failure. Nephrotic syndrome was diagnosed in patients with proteinuria greater than 3.5 g/24 hours and a serum albumin less than 30 g/L with or without oedema. Nephritic syndrome was diagnosed in patients with haematuria, proteinuria (less than 3.5 g/24 hours) and oedema with or without hypertension (systolic pressure ≥ 140 mmHg and diastolic pressure ≥ 90 mmHg). Asymptomatic urinary abnormalities included patients with persistent proteinuria less than 3.0 g/24 hours with or without microscopic haematuria. Acute renal failure was defined as a rapid decline in renal function and chronic renal failure was considered in patients with serum creatinine levels above 115 µmol/L that persisted for more than six months.
Three renal biopsy specimens were taken from each patient and evaluated by the same pathologist. Sections were made from formalin fixed paraffin embedded tissue and stained by haematoxylin-eosin (HE), periodic-acid Schiff, periodic acid-methenamine silver and Masson's trichrome stains. All biopsies were conventionally processed for light microscopy and immunofluorescence. Immunofluorescence microscopy panels included staining for: IgA, IgM, IgG, C3, C1q and fibrinogen. Electron microscopy was not systematically performed.
Statistical analysis
Data were stored in a database file (Excel 2003). All statistical calculations were carried out with the statistical package SPSS for Windows 17.0. Age is reported as the mean ± standard error (SE). The analysis of variance was used to test the significance of differences. Frequency counts were compared using the Chi-squared test. P-values < 0.05 were considered significant.
RESULTS
Among 5115 cases, PGD was the most common finding (n = 3817; 74.93%). In addition to 95 paediatric cases, there were 3722 adult cases of primary glomerulonephritis analysed. Table 1 shows the clinical presentation and the distribution of the various types of primary glomerulonephritis. There was a statistically significant association between the clinical and pathological types of primary glomerulonephritis (Χ 2 = 2439.77, p = 0.003). Among the 3722 adult renal biopsies, nephrotic and nephritic syndromes were the two most com- The most common cause of nephrotic syndrome was MN (n = 795; 44%), followed by MCD (n = 456, 25.24%) and IgA nephropathy (n = 318, 17.60%). Immunoglobulin A nephropathy was the leading cause of nephritic syndrome, asymptomatic urinary abnormalities and chronic renal failure, accounting for 56.85% (n = 718), 61.75% (n = 297) and 47.06% (n = 64), respectively. The most common cause of acute renal failure was crescentic glomerulonephritis (n = 23; 65.71%). Table 2 shows the age distribution of the histopathological lesions. There was a statistically significant association between the nine pathological types (F = 21.03, p = 0.001). At the time of the renal biopsies, the mean age of the patients with PGD was 38.50 years (SD 14.159) with a range of 14 to 84 years. Patients with MPGN were the oldest (mean age 46.13 years), followed by those with crescentic glomerulonephritis (mean age 44.59 years) and MN (mean age 42.82 years). The patients with MCD were the youngest (mean age 34.07 years). Table 3 Table 4 shows the annual distribution of the various types of primary glomerulonephritis. There was a statistically significant association among the analysed data for six years (7). Renal biopsy has been performed on a large scale in the basic-level hospitals of Shandong province since 2006; however, a centralized collection of clinical data, and follow-up of patients after renal biopsy, has not been developed. There has been no single study with a large sample size to demonstrate statistical conclusions in Shandong province. It is well known that a review of renal biopsy data might provide insights into the spectrum of clinically significant renal disease in a given community. Because the diagnosis of secondary glomerular disease mainly depends on clinical as well as renal biopsy pathology examination, data from these evaluations are very meaningful to the diagnosis of primary glomerular nephritis. This study reports on the results of 3722 renal biopsies collected from adults over a period of six years and analysed retrospectively.
Among the primary glomerular diseases, the various conditions differ in incidence among different studies. This survey showed that IgA nephropathy was the most common cause of PGD (37.72%). The high incidence of IgA nephropathy was in accordance with previously published studies from east Asia (8-11), Hungary (12) and western Europe (13) . This is in contrast to the results of studies performed in southwestern Asia and northern Africa that have reported a high incidence of FSGS (14-16) ; a high prevalence of MCD has also been reported from southeastern Asia (17, 18) . The criteria used for selecting patients for renal biopsy, as well as geographic and ethnic factors, may account for these variations. Racial differences may explain geographic differences in the frequency of IgA nephropathy; east Asians may be more susceptible to this disease.
The results of this study show that the mean age of patients with IgA nephropathy was 36.95 years, 1.55 years less than the mean age of 38.50 years for the total group. It is well known that IgA nephropathy is more frequent in younger patients and most commonly presents with asymptomatic abnormalities in the urine with normal renal function. On the other hand, a minority of patients have presented with clinical/histological evidence of rapidly progressive glomerulonephritis (19) with rapid progression to ESRD. Therefore, the clinical presentation and prognosis for patients with IgA nephropathy is highly variable (20, 21) , which suggests that it may encompass multiple subsets of disease that are not distinguishable by the clinical tools currently available. In other words, immunoglobulin A is not likely pathogenic, but is an important factor. Further studies are needed to improve understanding of the pathophysiology of this disease as well as the precipitating factors; such improvements will likely result in better treatment and improved health status among people living in China.
The primary indication for a renal biopsy in the group studied here was nephrotic syndrome (48.55%). Two possible explanations for this are severe oedema which alerted patients to seek help, and that most patients with nephrotic syndrome had no contraindications to a renal biopsy. Membranous glomerulonephritis was the leading cause of nephrotic syndrome in adults; it was present in 44% of the study patients. Similar observations were reported from Beijing (22) and Spain (23) . One possible reason is that children were excluded from the data analysis; the pathology in children was mostly MCD.
The results of this study showed that the young (19-39 years) and middle-aged (40-59 years) patients accounted for most of the cases of PGD (86%) that underwent renal biopsy; older men and teenagers were less likely to have this procedure, as determined by the incidence of PGD and their tolerance for a renal biopsy. Immunoglobulin A nephropathy was the most common pathological type in teenagers, the young and the middle-aged, while MN was more common in older men. According to the data on mean age, as noted in Table 2 , crescentic glomerulonephritis was the pathological type associated with the oldest age group, MN came next and MCD was the most common pathological type in the youngest age group. These findings are consistent with a prior study from northeastern China (7). It is well known that patients with crescentic glomerulonephritis and MN are difficult to cure and their prognosis is poor; however, for MCD, the prognosis is good. These findings suggest that an older age of onset is associated with a poorer prognosis.
An important finding of this study, of data collected over six years, was that MN had a significant percentage increase and MesPGN significantly decreased. The same trend has also been observed in Korea (8) , Singapore (9), Brazil (24) and Estonia (25) . Primary glomerulonephritis was divided into inflammatory glomerulopathies and non-inflammatory glomerulopathies, the former included MesPGN, IgA nephropathy and MPGN, and the latter included MN, MCD and FSGS. The decreased prevalence of inflammatory glomerulopathies is probably associated with better control of chronic persistent viral and bacterial infections. Noninflammatory glomerulopathies that increased in frequency might be explained by the improvement of living standards and an increase in the average lifespan. This trend has been reported in studies over a long period of time (10-30 years). Whether the changes observed in this study are related to environmental factors or the frequency of infections remains unknown. However, the availability of electron microscopy and technical improvements for diagnosis likely played a major role.
There are several limitations to this study. Firstly, the diagnosis in certain cases, such as in MCD and FSGS, could not be diagnosed with certainty without an electron microscope. Secondly, not all patients with glomerular disease were biopsied so the true prevalence of primary glomerular disease was underestimated. Thirdly, the time span of six years used in this study is relatively short.
In summary, the pattern identified in the data from patients analysed in this study tended to reflect less severe glomerular lesions, mainly due to the criteria used for selection of patients to undergo renal biopsy. To obtain more precise epidemiological data, it will be necessary to establish a National Renal Biopsy Registry with a unified biopsy policy and standardized collection of clinical data as well as follow-up of patients after renal biopsies.
